Smartleaf Asset Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.85K Buy
329
+123
+60% +$772 ﹤0.01% 3062
2026
Q2
$1.16K Hold
206
– – ﹤0.01% 3076
2026
Q1
$834 Buy
+206
New +$1.15K ﹤0.01% 3149

Other funds holding NUVB

Smartleaf Asset Management's NUVB Position: Q3 2026 in Review

Smartleaf Asset Management increased its Nuvation Bio (NUVB) stake by 60% in Q3 2026, buying an estimated $772 and bringing the position to 329 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3062.

Smartleaf Asset Management first reported a position in NUVB in Q1 2026 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Smartleaf Asset Management held 329 shares of Nuvation Bio worth $1.85K as of Q3 2026.
  • Smartleaf Asset Management bought 123 Nuvation Bio shares in Q3 2026, an estimated $772.
  • Nuvation Bio made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3062 holding.
  • Smartleaf Asset Management first reported a position in Nuvation Bio in Q1 2026 and has held it in 3 quarters since.
  • 208 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.